- Home
- EVH vs QTRX Comparison
EVH vs QTRX Comparison
Compare EVH & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVH | QTRX |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.4M | 306.0M |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVH | QTRX |
|---|---|---|
| Price | $3.46 | $3.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $7.93 | $6.00 |
| AVG Volume (30 Days) | ★ 2.8M | 950.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,957,000.00 | $37,632,000.00 |
| Revenue This Year | $33.89 | $25.49 |
| Revenue Next Year | $15.84 | $10.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $2.10 | $3.04 |
| 52 Week High | $11.92 | $8.77 |
Technical Indicators
Market Signals| Indicator | EVH | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.67 | 35.14 |
| Support Level | $2.53 | N/A |
| Resistance Level | $4.20 | $3.81 |
| Average True Range (ATR) | 0.28 | 0.23 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 84.00 | 25.66 |
Price Performance
Historical ComparisonAbout EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.